Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Incidence of Post-Transplant Lymphoproliferative Disease: A Systematic Literature Review

Dhanalakshmi Thirumalai, Crystal Watson, Pengcheng Xun, Natalia Sadetsky, Kassandra Schaible, Arie Barlev

Blood (2021) 138 (Supplement 1): 4564.

https://doi.org/10.1182/blood-2021-147715

Published: 2021

Journal Articles

Quantification of Long-Term Consequences Associated with Components of the CHOP Chemotherapy Regimen

Crystal Watson, Hemanth Gadikota, Arie Barlev, Rachel Beckerman

Blood (2021) 138 (Supplement 1): 4589.

https://doi.org/10.1182/blood-2021-145037

Published: 2021

Journal Articles

An Evidence Review of the Long-Term Consequences Associated with Components of the CHOP Chemotherapy Regimen in Transplant Recipients

Crystal Watson, Hemanth Gadikota, Arie Barlev, Rachel Beckerman

Blood (2021) 138 (Supplement 1): 4586.

https://doi.org/10.1182/blood-2021-147242

Published: 2021

Journal Articles

ATHN Transcends: A Natural History Cohort Study of the Safety, Effectiveness and Practice of Treatment in People with Non-Neoplastic Hematologic Disorders

Lynn M Malec, Nikki Hirsh, Carrie O'Neill, Crystal Watson, Michael Recht

Blood (2021) 138 (Supplement 1): 4242.

https://doi.org/10.1182/blood-2021-148209

Published: 2021

Journal Articles

Hemophilia Natural History Study (ATHN 7): Baseline Characteristics, Adverse Events, and Self-Reported Health Status of Individuals with Hemophilia a and B

Tyler W. Buckner, MDMSc, Shannon L Carpenter, MD, Stacy E. Croteau, MD, Adam Cuker, MDMS, Nabil Daoud, MA, Christine L Kempton, MDMSc, Lynn M Malec, MD, Thomas W. McLean, MD, Leslie J. Raffini, MD, Janice M Staber, MD, Michael Wang, MD, Crystal Watson, BS, Ayesha Zia, MD, Michael Recht, MD PhD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-137696

Published: 2020

Journal Articles

Results of Genetic Analysis of 11,341 Participants Enrolled in the My Life, Our Future (MLOF) Hemophilia Genotyping Initiative

Jill M Johnsen, MD, Shelley N Fletcher, Angela Dove, Haley McCracken, Beth K Martin, Martin Kircher, Neil C Josephson, MD, Jay Shendure, Sarah Ruuska, MPH, Leonard A. Valentino, MD, Glenn Pierce, MD PhD, Crystal Watson, BS, Dunlei Cheng, PhD, Michael Recht, MD PhD, Barbara A. Konkle, MD

Blood (2020) 136 (Supplement 1): 19.

https://doi.org/10.1182/blood-2020-140649

Published: 2020

Journal Articles

Bleeding in Patients with Clinically Severe Von Willebrand Disease: Preliminary Results of Athn 9, a Natural History Study of the Safety, Effectiveness, and Practice of Treatment for People with Severe Von Willebrand Disease (VWD)

Angela C. Weyand, MD, Kenneth D Friedman, MD, Sweta Gupta, MD, Kristina M. Haley, DO, Chunla He, Salley Pels, MD, Jonathan C. Roberts, MD, Crystal Watson, BS, Robert F. Sidonio, Jr., MD MSc.

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-137124

Published: 2020

Journal Articles

U.S. Cohort Study of Previously Untreated Patients with Congenital Hemophilia (ATHN 8: PUPs Study): Association between Family History and Age of Diagnosis

Courtney D Thornburg, MD, Kenneth D Friedman, MD, Michael F Guerrera, MD, Chunla He, Lynn M Malec, MD, Mindy L Simpson, MD, Michael D Tarantino, MD, H. Marijke Van Den Berg, Crystal Watson, BS, Shannon L Carpenter, MD

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-138748

Published: 2020

Journal Articles

Athn 15: Characterizing the Real-World Use of Direct Oral Anticoagulants in Pediatric Patients - Interim Analysis

Jennifer G. Davila, MD, Fernando F. Corrales-Medina, MD, Dunlei Cheng, PhD, Leslie J. Raffini, MD, Courtney D Thornburg, MD, Crystal Watson, BS

Blood (2020) 136 (Supplement 1): 19–20.

https://doi.org/10.1182/blood-2020-137113

Published: 2020

Journal Articles

The Economic Burden of Short-Term Adverse Events Associated with the CHOP Chemotherapy Regimen in Patients with Lymphoproliferative Disorders in the United States: A Comprehensive Literature Review

Crystal Watson, MS, Arie Barlev, PharmD, Jodie Worrall, Steve Duff, MS, Rachel Beckerman, PhD

Blood (2019) 134 (Supplement_1): 5826.

https://doi.org/10.1182/blood-2019-122611

Published: 2019

Journal Articles

Assessing the Safety of Various VWF Regimens in Patients with Clinically Severe VWD: A Natural History Study

Robert F. Sidonio, Jr., MD MSc, Angela C. Weyand, MD, Dunlei Cheng, PhD, Crystal Watson

Blood (2019) 134 (Supplement_1): 1132.

https://doi.org/10.1182/blood-2019-128318

Published: 2019

Journal Articles

Lack of Inhibitor Development in the American Thrombosis and Hemostasis Network (ATHN)-2 Factor Switching Study: Preliminary Report of Primary Outcome

Robert F. Sidonio, Jr., MD MSc, Dunlei Cheng, PhD, Christine Guelcher, PPCNP-BC, Janna M. Journeycake, MD, Susan U Lattimore, Clifford Takemoto, MD, Michael D. Tarantino, MD, Crystal Watson, Ellis J. Neufeld, MD, Carol Fedor, RN

Blood (2019) 134 (Supplement_1): 1114.

https://doi.org/10.1182/blood-2019-128612

Published: 2019

Journal Articles

Burden of Hospitalizations Due to Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorder (EBV + PTLD) in Patients Who Failed First Line Rituximab or Rituximab Plus Chemotherapy Following Solid Organ Transplant (Post-SOT): A Retrospective Chart Review Study of German PTLD Registry

Heiner Zimmermann, MD, Hairong Xu, MD PhD, Arie Barlev, PharmD, Yang Zhang, PhD, Dhanalakshmi Thirumalai, Crystal Watson, MS, Ralf Ulrich Trappe, MD

Blood (2019) 134 (Supplement_1): 65.

https://doi.org/10.1182/blood-2019-124583

Published: 2019

Journal Articles

Novel Structural Variants Originating in F8 N on-Coding Regions in Previously Unresolved Cases of Severe Hemophilia A

Marsha M Wheeler, PhD, Barbara A Konkle, Crystal Watson, Glenn F. Pierce, Deborah A Nickerson, Jill M Johnsen, MD

Blood (2018) 132 (Supplement 1): 379.

https://doi.org/10.1182/blood-2018-99-112690

Published: 2018

Journal Articles

Estimating Long-Term Survival in a Cohort of Allogeneic Hematopoietic Stem Cell Transplant Patients

Stephen Palmer, MSc, Casey Quinn, PhD MPhil, Crystal Watson, MS, Arie Barlev, PharmD

Blood (2018) 132 (Supplement 1): 3556.

https://doi.org/10.1182/blood-2018-99-113616

Published: 2018

Journal Articles

A Systematic Literature Review of Real-World Evidence in Post-Transplant Lymphoproliferative Disorder

Hairong Xu, MD PhD, Anna Forsythe, PharmD, MSc, MBA, Arie Barlev, PharmD, Nazia Rashid, PharmD, Crystal Watson, MS

Blood (2018) 132 (Supplement 1): 5839.

https://doi.org/10.1182/blood-2018-99-113583

Published: 2018

Journal Articles

Risk of Patients Developing Post-Transplant Lymphoproliferative Disorder within the First Year after an Allogeneic Hemopoietic Stem Cell Transplant, 2011 to 2016: A US Claims Database Analysis

Arie Barlev, PharmD, Hairong Xu, MD PhD, Nicole Fulcher, MA, Crystal Watson, MS, Ila Sruti, MPH, Akshay Sudhindra, MD

Blood (2018) 132 (Supplement 1): 5840.

https://doi.org/10.1182/blood-2018-99-113598

Published: 2018

Journal Articles

Younger Patients Are Impacted By Post-Transplant Lymphoproliferative Disorder: Findings from a Systematic Literature Review of Real-World Evidence

Crystal Watson, MS, Hairong Xu, MD PhD, Anna Forsythe, PharmD, MSc, MBA, Shan Ashton Garib, MA, Arie Barlev, PharmD

Blood (2018) 132 (Supplement 1): 5841.

https://doi.org/10.1182/blood-2018-99-113622

Published: 2018

Journal Articles

Treatment Patterns for Patients with Post-Transplant Lymphoproliferative Disorder Who Fail Rituximab after Allogeneic Hematopoietic Stem Cell Transplantation: Findings from a Systematic Literature Review

Hairong Xu, MD PhD, Crystal Watson, MS, Shan Ashton Garib, MA, Anna Forsythe, PharmD, MSc, MBA, Arie Barlev, PharmD

Blood (2018) 132 (Supplement 1): 4777.

https://doi.org/10.1182/blood-2018-99-113593

Published: 2018

Journal Articles

Transition of Care for Pediatric and Adult Patients with Venous Thromboembolism in the American Thrombosis Hemostasis Network

Madhvi Rajpurkar, MD, Maura Malone, Jim Munn, RN, BSN, MS, Julie Jaffray, MD, Crystal Watson, Dunlei Cheng, PhD, Maria Teresa De Sancho, MD

Blood (2018) 132 (Supplement 1): 4711.

https://doi.org/10.1182/blood-2018-99-117533

Published: 2018

NARROW

Incidence of Post-Transplant Lymphoproliferative Disease: A Systematic Literature Review

Quantification of Long-Term Consequences Associated with Components of the CHOP Chemotherapy Regimen

An Evidence Review of the Long-Term Consequences Associated with Components of the CHOP Chemotherapy Regimen in Transplant Recipients

ATHN Transcends: A Natural History Cohort Study of the Safety, Effectiveness and Practice of Treatment in People with Non-Neoplastic Hematologic Disorders

Hemophilia Natural History Study (ATHN 7): Baseline Characteristics, Adverse Events, and Self-Reported Health Status of Individuals with Hemophilia a and B

Results of Genetic Analysis of 11,341 Participants Enrolled in the My Life, Our Future (MLOF) Hemophilia Genotyping Initiative

Bleeding in Patients with Clinically Severe Von Willebrand Disease: Preliminary Results of Athn 9, a Natural History Study of the Safety, Effectiveness, and Practice of Treatment for People with Severe Von Willebrand Disease (VWD)

U.S. Cohort Study of Previously Untreated Patients with Congenital Hemophilia (ATHN 8: PUPs Study): Association between Family History and Age of Diagnosis

Athn 15: Characterizing the Real-World Use of Direct Oral Anticoagulants in Pediatric Patients - Interim Analysis

The Economic Burden of Short-Term Adverse Events Associated with the CHOP Chemotherapy Regimen in Patients with Lymphoproliferative Disorders in the United States: A Comprehensive Literature Review

Assessing the Safety of Various VWF Regimens in Patients with Clinically Severe VWD: A Natural History Study

Lack of Inhibitor Development in the American Thrombosis and Hemostasis Network (ATHN)-2 Factor Switching Study: Preliminary Report of Primary Outcome

Burden of Hospitalizations Due to Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorder (EBV + PTLD) in Patients Who Failed First Line Rituximab or Rituximab Plus Chemotherapy Following Solid Organ Transplant (Post-SOT): A Retrospective Chart Review Study of German PTLD Registry

Novel Structural Variants Originating in F8 N on-Coding Regions in Previously Unresolved Cases of Severe Hemophilia A

Estimating Long-Term Survival in a Cohort of Allogeneic Hematopoietic Stem Cell Transplant Patients

A Systematic Literature Review of Real-World Evidence in Post-Transplant Lymphoproliferative Disorder

Risk of Patients Developing Post-Transplant Lymphoproliferative Disorder within the First Year after an Allogeneic Hemopoietic Stem Cell Transplant, 2011 to 2016: A US Claims Database Analysis

Younger Patients Are Impacted By Post-Transplant Lymphoproliferative Disorder: Findings from a Systematic Literature Review of Real-World Evidence

Treatment Patterns for Patients with Post-Transplant Lymphoproliferative Disorder Who Fail Rituximab after Allogeneic Hematopoietic Stem Cell Transplantation: Findings from a Systematic Literature Review

Transition of Care for Pediatric and Adult Patients with Venous Thromboembolism in the American Thrombosis Hemostasis Network

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only